FDA Stops Emergency Use of Hydroxychloroquine as it 'Weakens' Effectiveness of Remdesivir
Ibtimes·2020-06-16 13:21
The U.S. Food and Drug Administration (FDA) on Monday warned against using a combination of anti-malaria drug hydroxychloroquine and Gilead's experimental remdesivir on Covid-19 patients, as it could substantially reduce the effectiveness of the drug. The announcement came hours after the FDA revoked the emergency use of hydroxychloroquine as a potential Covid-19 treatment.
……America Health Finance International
One-stop lifestyle app dedicated to making life in Singapore a breeze!
Comments
Leave a comment in Nestia App